BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31174957)

  • 1. Impact of rhabdoid differentiation on postoperative outcome for patients with N0M0 renal cell carcinoma.
    Kim H; Inomoto C; Uchida T; Kajiwara H; Komiyama T; Kobayashi H; Nakamura N; Miyajima A
    Urol Oncol; 2019 Oct; 37(10):711-720. PubMed ID: 31174957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of tumor size on patient survival after radical nephrectomy for pathological T3a renal cell carcinoma.
    Sugiyama Y; Yatsuda J; Murakami Y; Ito N; Yamasaki T; Mikami Y; Ogawa O; Kamba T
    Jpn J Clin Oncol; 2019 May; 49(5):465-472. PubMed ID: 30793163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.
    Albisinni S; Pretot D; Al Hajj Obeid W; Aoun F; Quackels T; Peltier A; Roumeguère T
    Prog Urol; 2019; 29(8-9):423-431. PubMed ID: 31196826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Factor in Patients Undergoing Nephrectomy for Non-Metastatic Renal Cell Carcinoma: Propensity Score Matching Analysis.
    Won I; Shim SR; Kim SI; Kim SJ; Cho DS
    Clin Genitourin Cancer; 2022 Jun; 20(3):e253-e262. PubMed ID: 35241381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
    O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
    World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes.
    Psutka SP; Heidenreich M; Boorjian SA; Bailey GC; Cheville JC; Stewart-Merrill SB; Lohse CM; Atwell TD; Costello BA; Leibovich BC; Thompson RH
    BJU Int; 2017 Jan; 119(1):116-127. PubMed ID: 27489013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type II papillary histology predicts poor outcome in patients with renal cell carcinoma and vena cava thrombus.
    Kim KH; You D; Jeong IG; Kwon TW; Cho YM; Hong JH; Ahn H; Kim CS
    BJU Int; 2012 Dec; 110(11 Pt B):E673-8. PubMed ID: 22973869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality Increases When Radical Nephrectomy is Delayed More Than 60 Days for T3 Renal Cell Carcinoma.
    Zhao F; Liu X; Zhang C; Zhu H; Qi N
    Technol Cancer Res Treat; 2021; 20():15330338211043963. PubMed ID: 34595976
    [No Abstract]   [Full Text] [Related]  

  • 11. Stage T1N0M0 renal cell carcinoma: the prognosis in Asian patients.
    Zhang ZL; Chen W; Li YH; Liu ZW; Luo JH; Lau W; Tan MH; Zhou FJ
    Chin J Cancer; 2011 Nov; 30(11):772-8. PubMed ID: 22035858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically.
    Yang B; Xia H; Xu C; Lu M; Zhang S; Wang G; Ma L
    BMC Urol; 2020 Feb; 20(1):14. PubMed ID: 32070319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
    Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP; Ogan K; Bilen MA; Master VA
    Cancer; 2021 Jun; 127(12):1974-1983. PubMed ID: 33760232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
    Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
    Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncological outcome of surgical treatment in 336 patients with renal cell carcinoma.
    Zhang ZL; Li YH; Xiong YH; Hou GL; Yao K; Dong P; Liu ZW; Han H; Qin ZK; Zhou FJ
    Chin J Cancer; 2010 Dec; 29(12):995-9. PubMed ID: 21114919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell Carcinoma.
    Patel P; Nayak JG; Liu Z; Saarela O; Jewett M; Rendon R; Kapoor A; Black P; Tanguay S; Kawakami J; Moore R; Breau RH; Morash C; Pouliot F; Drachenberg DE
    J Endourol; 2017 Jul; 31(7):645-650. PubMed ID: 28381117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of several histopathological prognosticators and local tumour extension on oncological outcome in pT3b/c N0M0 renal cell carcinoma.
    Roos FC; Weirich J; Victor A; Elsässer A; Brenner W; Biesterfeld S; Hampel C; Thüroff JW
    BJU Int; 2009 Aug; 104(4):461-9. PubMed ID: 19338563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
    Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T
    BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
    Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
    Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of tumor size on oncological outcomes of pathological T3aN0M0 renal cell carcinoma treated by radical nephrectomy.
    Chen L; Ma X; Li H; Gu L; Li X; Gao Y; Xie Y; Zhang X
    PLoS One; 2017; 12(3):e0173953. PubMed ID: 28288191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.